Cargando…

Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19

Detalles Bibliográficos
Autores principales:	Gong, Wenping, Liu, Yinping, Xue, Yong, Zhuang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242049/ https://www.ncbi.nlm.nih.gov/pubmed/37287961 http://dx.doi.org/10.3389/fimmu.2023.1207212

Ejemplares similares

A comprehensive approach to developing a multi-epitope vaccine against Mycobacterium tuberculosis: from in silico design to in vitro immunization evaluation
por: Jiang, Fan, et al.
Publicado: (2023)

The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues
por: Gong, Wenping, et al.
Publicado: (2022)

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
por: Du, Jingli, et al.
Publicado: (2023)

IFN-γ, should not be ignored in SLE
por: Liu, Wenping, et al.
Publicado: (2022)

Excluding Participants With Mycobacteria Infections From Clinical Trials: A Critical Consideration in Evaluating the Efficacy of BCG Against COVID-19
por: Gong, Wenping, et al.
Publicado: (2023)

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
por: Covián, Camila, et al.
Publicado: (2019)

Exploring BCG vaccination as a novel approach to prevent recurrent herpes labialis
por: Gong, Wenping, et al.
Publicado: (2023)

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory
por: da Costa, Adeliane Castro, et al.
Publicado: (2014)

Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial
por: dos Anjos, Laura Raniere Borges, et al.
Publicado: (2022)

BCG and Adverse Events in the Context of Leprosy
por: Richardus, Renate, et al.
Publicado: (2018)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

A Perspective on the Success and Failure of BCG
por: Kumar, Pawan
Publicado: (2021)

Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory
por: Lv, Wei, et al.
Publicado: (2022)

Corrigendum: A Perspective on the Success and Failure of BCG
por: Kumar, Pawan
Publicado: (2022)

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
por: Lim, Chun Jye, et al.
Publicado: (2021)

Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
por: Gong, Wenping, et al.
Publicado: (2021)

ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk
por: Tsilika, Maria, et al.
Publicado: (2022)

The BCG Vaccine for COVID-19: First Verdict and Future Directions
por: Gonzalez-Perez, Maria, et al.
Publicado: (2021)

Impact of BCG vaccination on the repertoire of human γδ T cell receptors
por: Xia, Mei, et al.
Publicado: (2023)

Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk
por: Tsilika, Maria, et al.
Publicado: (2022)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
por: Kaufmann, Stefan H. E.
Publicado: (2020)

Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19
por: Morrison, Alexandra L., et al.
Publicado: (2021)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents
por: Gong, Wenping, et al.
Publicado: (2022)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
por: Dockrell, Hazel M., et al.
Publicado: (2017)

BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity
por: Abate, Getahun, et al.
Publicado: (2019)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
por: Bickett, Thomas E., et al.
Publicado: (2020)

Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in Humans
por: James, Charlotte A., et al.
Publicado: (2022)

BCG vaccination policy, natural boosting and pediatric brain and CNS tumor incidences
por: Singh, Samer, et al.
Publicado: (2023)

Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction
por: Mizuno, Satoru, et al.
Publicado: (2023)

Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
por: Messina, Nicole L., et al.
Publicado: (2023)

Corrigendum: Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB
por: Cheng, Peng, et al.
Publicado: (2023)

Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB
por: Cheng, Peng, et al.
Publicado: (2023)

When and how should we cluster and cross over: methodological and ethical issues
por: Goldstein, Cory E., et al.
Publicado: (2018)

Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations
por: Uthayakumar, Deeva, et al.
Publicado: (2018)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
por: Diogo, Gil R., et al.
Publicado: (2019)

Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population
por: Yang, Qing-yuan, et al.
Publicado: (2021)

BCG mediated protection of the lung against experimental SARS-CoV-2 infection
por: Hilligan, Kerry L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_atmacjq7bftls2lr4r6b1s62pq